PATENTS; PRIOR ART. As of the Option Exercise Date and to the best of Isis’ knowledge, it has the sufficient legal and/or beneficial title and ownership under the Isis Technology as is necessary to fulfill its obligations under this Agreement and to grant the licenses and options to license to Lilly pursuant to this Agreement. Isis is not aware of any communications alleging that it has violated or, by conducting its business as currently proposed under this Agreement, would violate any of the intellectual property rights of any Third Party;
Appears in 1 contract
Samples: Drug Development and License Option Agreement (Isis Pharmaceuticals Inc)
PATENTS; PRIOR ART. As of the Option Exercise Effective Date and to the best of Isis’ ' knowledge, it has the sufficient legal and/or beneficial title and ownership under the Isis 37. Technology as is necessary to fulfill its obligations under this Agreement and to grant the licenses and options to license to Lilly pursuant to this Agreement. Isis is not aware of any communications alleging that it has violated or, by conducting its business as currently proposed under this Agreement, would violate any of the intellectual property rights of any Third Party;
Appears in 1 contract
PATENTS; PRIOR ART. As of the Option Exercise Effective Date and to the best of Isis’ knowledge, it has the sufficient legal and/or beneficial title and ownership under the Isis Technology as is necessary to fulfill its obligations under this Agreement and to grant the licenses and options to license to Lilly pursuant to this Agreement. Isis is not aware of any communications alleging that it has violated or, by conducting its business as currently proposed under this Agreement, would violate any of the intellectual property rights of any Third Party;
Appears in 1 contract
PATENTS; PRIOR ART. As of the Option Exercise Effective Date and to the best of Isis’ ' knowledge, it has the sufficient legal and/or beneficial title and ownership under the Isis Technology as is necessary to fulfill its obligations under this Agreement and to grant the licenses and options to license to Lilly pursuant to this Agreement. Isis is not aware of any communications alleging that it has violated or, by conducting its business as currently proposed under this Agreement, would violate any of the intellectual property rights of any Third Party;
Appears in 1 contract